US BioTek Laboratories Expands Diagnostic Testing Portfolio with Acquisition of RealTime Laboratories

US BioTek Laboratories (“US BioTek”), a Clinical Laboratory Improvement Amendments (CLIA) and CAP accredited laboratory, announces the acquisition of Dallas, TX-based RealTime Laboratories (“RealTime”), a pioneer in the field of mycotoxin testing. The transaction expands the capabilities, expertise, and geographic footprint of the combined organization, providing more testing options to customers and accelerating the development of new diagnostic tests. Founded in 2005, RealTime is a CAP and CLIA accredited clinical and environmental diagnostic laboratory that specializes in testing for and identifying hazardous toxins from mold (mycotoxins) in humans, houses and animals, as well as infectious diseases.

Read the full article: US BioTek Laboratories Expands Diagnostic Testing Portfolio with Acquisition of RealTime Laboratories //

Source: https://www.prnewswire.com/news-releases/us-biotek-laboratories-expands-diagnostic-testing-portfolio-with-acquisition-of-realtime-laboratories-302092494.html

Leave a Comment

Your email address will not be published.

Scroll to Top